Interim Condensed Consolidated Statement of Financial Position

as of June 30, 2021, Unaudited, and December 31, 2020

Assets

June 30, 2021

(Unaudited)

December 31, 2020
USD `000 USD `000
Non-current Assets:
Other non-current assets 3 3
Total non-current assets 3 3
Prepaid expenses 224 337
Other receivables 182 91
Income tax receivable 190 196
Cash and cash equivalents 75,097 79,087
Total current assets 75,693 79,711
Total assets 75,696 79,714

Equity and Liabilities

June 30, 2021

(Unaudited)

December 31, 2020
USD `000 USD `000
Share capital 157 154
Other components of equity:
Foreign currency translation reserve 90,808 93,315
Accumulated deficit (15,856 ) (14,825 )
Equity attributable to shareholders of the Parent 75,109 78,644
Total equity 75,109 78,644
Trade payables 30 476
Accrued liabilities 557 594
Total current liabilities 587 1,070
Total equity and liabilities 75,696 79,714

Attachments

  • Original document
  • Permalink

Disclaimer

Forward Pharma A/S published this content on 31 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 August 2021 21:01:08 UTC.